Page 1 of 1

First patient enrolled in head-to-head study of MS treatment

Posted: Thu Mar 25, 2010 12:45 am
by MSUK
Study to evaluate possible benefits of switching to Tysabri from Copaxone or Rebif commences. - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1768

Posted: Thu Mar 25, 2010 2:01 am
by sbr487
Here is the verdict - Tsyabri almost always improves the MS conditons in nearly all the patients.